1
|
Jauch EC, Saver JL, Adams HP Jr, et al:
American Heart Association Stroke Council; Council on
Cardiovascular Nursing; Council on Peripheral Vascular Disease;
Council on Clinical Cardiology: Guidelines for the early management
of patients with acute ischemic stroke: A guideline for healthcare
professionals from the American Heart Association/American Stroke
Association. Stroke. 44:870–947. 2013. View Article : Google Scholar : PubMed/NCBI
|
2
|
Wei YL, Liu ZL and Duan XQ: Analysis of
prognostic factors of feeding-swallowing disorder patients in
stroke unit. Zhong Guo Kang Fu Yi Xue Za Zhi. 25:322–325. 2010.(In
Chinese).
|
3
|
Bradberry JC, Fagan SC, Gray DR and Moon
YS: New perspectives on the pharmacotherapy of ischemic stroke. J
Am Pharm Assoc (2003). 44:(2 Suppl 1). S46–56. 2004. View Article : Google Scholar : PubMed/NCBI
|
4
|
Kim JM, Stewart R, Kang HJ, et al: A
prospective study of statin use and poststroke depression. J Clin
Psychopharmacol. 34:72–79. 2014. View Article : Google Scholar : PubMed/NCBI
|
5
|
Schneider MA and Schneider MD: Recognizing
poststroke depression. Nursing. 42:60–63. 2012. View Article : Google Scholar : PubMed/NCBI
|
6
|
Del Zoppo GJ, Saver JL, Jauch EC and Adams
HP Jr: American Heart Association Stroke Council: Expansion of the
time window for treatment of acute ischemic stroke with intravenous
tissue plasminogen activator: A science advisory from the American
Heart Association/American Stroke Association. Stroke.
40:2945–2948. 2009. View Article : Google Scholar : PubMed/NCBI
|
7
|
Videbech P and Ravnkilde B: Hippocampal
volume and depression: A meta-analysis of MRI studies. Am J
Psychiatry. 161:1957–1966. 2004. View Article : Google Scholar : PubMed/NCBI
|
8
|
Kunze A, Zierath D, Drogomiretskiy O and
Becker K: Strain differences in fatigue and depression after
experimental stroke. Transl Stroke Res. 5:604–611. 2014. View Article : Google Scholar : PubMed/NCBI
|
9
|
Wang SH, Zhang ZJ, Guo YJ, Sui YX and Sun
Y: Involvement of serotonin neurotransmission in hippocampal
neurogenesis and behavioral responses in a rat model of post-stroke
depression. Pharmacol Biochem Behav. 95:129–137. 2010. View Article : Google Scholar : PubMed/NCBI
|
10
|
Tuglu C, Kara SH, Caliyurt O, Vardar E and
Abay E: Increased serum tumor necrosis factor-alpha levels and
treatment response in major depressive disorder. Psychopharmacology
(Berl). 170:429–433. 2003. View Article : Google Scholar : PubMed/NCBI
|
11
|
Basso AM, Bratcher NA, Harris RR, Jarvis
MF, Decker MW and Rueter LE: Behavioral profile of P2X7 receptor
knockout mice in animal models of depression and anxiety: Relevance
for neuropsychiatric disorders. Behav Brain Res. 198:83–90. 2008.
View Article : Google Scholar : PubMed/NCBI
|
12
|
Spalletta G, Bossù P, Ciaramella A, Bria
P, Caltagirone C and Robinson RG: The etiology of poststroke
depression: A review of the literature and a new hypothesis
involving inflammatory cytokines. Mol Psychiatry. 11:984–991. 2006.
View Article : Google Scholar : PubMed/NCBI
|
13
|
Craft TK and DeVries AC: Role of IL-1 in
poststroke depressive-like behavior in mice. Biol Psychiatry.
60:812–818. 2006. View Article : Google Scholar : PubMed/NCBI
|
14
|
Aarnio K, Haapaniemi E, Melkas S, Kaste M,
Tatlisumak T and Putaala J: Long-term mortality after first-ever
and recurrent stroke in young adults. Stroke. 45:2670–2676. 2014.
View Article : Google Scholar : PubMed/NCBI
|
15
|
Zweckberger K, Juettler E, Bösel J and
Unterberg WA: Surgical aspects of decompression craniectomy in
malignant stroke: Review. Cerebrovasc Dis. 38:313–323. 2014.
View Article : Google Scholar : PubMed/NCBI
|
16
|
Diener HC, Bogousslavsky J, Brass LM, et
al: MATCH investigators: Aspirin and clopidogrel compared with
clopidogrel alone after recent ischaemic stroke or transient
ischaemic attack in high-risk patients (MATCH): Randomised,
double-blind, placebo-controlled trial. Lancet. 364:331–337. 2004.
View Article : Google Scholar : PubMed/NCBI
|
17
|
Park GY, Im S, Oh CH, Lee SJ and Pae CU:
The association between the severity of poststroke depression and
clinical outcomes after first-onset stroke in Korean patients. Gen
Hosp Psychiatry. Mar 11–2015.(Epub ahead of print). View Article : Google Scholar : PubMed/NCBI
|
18
|
Henn FA and Vollmayr B: Neurogenesis and
depression: Etiology or epiphenomenon? Biol Psychiatry. 56:146–150.
2004. View Article : Google Scholar : PubMed/NCBI
|
19
|
Tharwani HM, Yerramsetty P, Mannlli P,
Patkar A and Masand P: Recent advances in poststroke depression.
Curr Psychiatry Rep. 9:225–231. 2007. View Article : Google Scholar : PubMed/NCBI
|
20
|
Boggio PS, Amancio EJ, Correa CF, et al:
Transcranial DC stimulation coupled with TENS for the treatment of
chronic pain: A preliminary study. Clin J Pain. 25:691–695. 2009.
View Article : Google Scholar : PubMed/NCBI
|
21
|
Morrissette DA and Stahl SM: Modulating
the serotonin system in the treatment of major depressive disorder.
CNS Spectr. 19:(Suppl 1). 57–67. 2014. View Article : Google Scholar : PubMed/NCBI
|
22
|
Hoffman RE, Gueorguieva R, Hawkins KA, et
al: Temporoparietal transcranial magnetic stimulation for auditory
hallucinations: Safety, efficacy and moderators in a fifty patient
sample. Biol Psychiatry. 58:97–104. 2005. View Article : Google Scholar : PubMed/NCBI
|
23
|
Holmes J: An attachment model of
depression: Integrating findings from the mood disorder laboratory.
Psychiatry. 76:68–86. 2013.PubMed/NCBI
|
24
|
Yang A, Hua P, Shang X, Cui Z, Zhong S,
Gong G and William Humphreys G: Deficiency of brain structural
sub-network underlying post-ischemic stroke apathy. Eur J Neurol.
22:341–347. 2015. View Article : Google Scholar : PubMed/NCBI
|
25
|
Lefaucheur JP: Stroke recovery can be
enhanced by using repetitive transcranial magnetic stimulation
(rTMS). Neurophysiol Clin. 36:105–115. 2006. View Article : Google Scholar : PubMed/NCBI
|